IRIS

1.1 Articolo in rivista: [15818] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 6.901 a 6.920 di 15.818
Titolo Data di pubblicazione Autore(i) File
Thyroglossal duct cyst carcinoma with concurrent thyroid carcinoma: a case report. J Med Case Reports. 2008 Apr 29;2:132 1-gen-2008 Gebbia, V; DI GREGORIO, C; Attard, M
Does an optimal therapeutic sequence exist in advanced non-small cell lung cancer? 1-gen-2008 Gebbia, V
Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale) 1-gen-2008 Gebbia, V; Galetta, D; Lorusso, V; Caruso, M; Verderame, F; Pezzella, G; Borsellino, N; Durini, E; Valenza, R; Agostara, B; Colucci, G; GRUPPO ONCOLOGICO ITALIA, Meridionale
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management 1-gen-2008 Mercadante, S; Porzio, G; Ferrera, P; Fulfaro, F; Aielli, F; Verna, L; Villari, P; Ficorella, C; Gebbia, V; Riina, S; Casuccio, A; Mangione, S
[First line chemotherapy in non-small cell lung carcinoma: a solved dilemma] 1-gen-2008 Gebbia, Vittorio
Adjuvant Therapy in Colon Cancer 1-gen-2009 Lombardi, L; Gebbia, V; Silvestris, N; Testa, A; Colucci, G; Maiello, E
Evolution of Therapy Decision-Making Process for Advanced Non-Small Cell Lung Cancer 1-gen-2009 Gebbia, V; Mancuso, G; Lombardi, L; Maiello, E
Third-line therapy for advanced non-small-cell lung cancer patients: a feasible therapeutic option? 1-gen-2009 Galetta, D; Rossi, A; Colucci, G; Gebbia, V
Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients. The DISTAL-2 randomized trial 1-gen-2009 Gebbia, V; Gridelli, C; Verusio, C; Frontini, L; Aitini, E; Daniele, B; Gamucci, T; Mancuso, G; DI MAIO, M; Gallo, C; Perrone, F; Morabito, A
Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer 1-gen-2009 Di Maio, M; Chiodini, P; Georgoulias, V; Hatzidaki, D; Takeda, K; Wachters, Fm; Gebbia, V; Smit, Ef; Morabito, A; Gallo, C; Perrone, F; Gridelli, C.
Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines 1-gen-2009 Vici, P; Giotta, F; DI Lauro, L; Brandi, M; Gebbia, V; Foggi, P; Lorusso, V; Vitucci, C; Sergi, D; Fattoruso, Si; Giannarelli, D; Viola, G; Corsetti, S; Colucci, G; Lopez, M.
Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients 1-gen-2009 Mercadante, S; Gebbia, V; David, F; Aielli, F; Verna, L; Casuccio, A; Porzio, G; Mangione, S; Ferrera, P.
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial 1-gen-2009 Pisano, C; Morabito, A; Sorio, R; Breda, E; Lauria, R; Gebbia, V; Scaltriti, L; Scalone, S; Zagonel, V; Greggi, S; Beneduce, G; Losito, S; Gallo, C; Di Maio, M; Forestieri, V; Pignata, S.
Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials 1-gen-2010 Gridelli, C; Morabito, A; Gebbia, Vittorio; Mencoboni, M; Carrozza, F; Viganò, Mg; Verusio, C; Bollina, R; Mattioli, R; Valerio, Maria Rosaria; Valmadre, G; Maione, P; Rossi, A; Cascone, T; Morgillo, F; Di Maio, M; Piccirillo, Mc; Gallo, C; Perrone, F; Ciardiello, F.
Scientific Activity and Needs Among Medical Oncology Units in Sicily: A Survey of The Italian Association of Medical Oncology 1-gen-2010 Amadio, P; Bordonaro, R; Borsellino, N; Butera, A; Caruso, M; Ferrau, F; Russello, R; Savio, G; Valenza, R; Zerilli, F; Gebbia, V
Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials 1-gen-2010 Di Maio, M; Lama, N; Morabito, A; Smit, Ef; Georgoulias, V; Takeda, K; Quoix, E; Hatzidaki, D; Wachters, Fm; Gebbia, V; Tsai, Cm; Camps, C; Schuette, W; Chiodini, P; Piccirillo, Mc; Perrone, F; Gallo, C; Gridelli, C.
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study 1-gen-2010 Colucci, G; Labianca, R; Di Costanzo, F; Gebbia, V; Cartenì, G; Massidda, B; Dapretto, E; Manzione, L; Piazza, E; Sannicolò, M; Ciaparrone, M; Cavanna, L; Giuliani, F; Maiello, E; Testa, A; Pederzoli, P; Falconi, M; Gallo, C; Di Maio, M; Perrone, F; Gruppo Oncologico Italia Meridionale, (GOIM); Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente, (GISCAD); Gruppo Oncologico Italiano di Ricerca Clinica, (GOIRC).
Clinicopathological Features of Pancreatic Endocrine Tumors: A Prospective Multicenter Study in Italy of 297 Sporadic Cases 1-gen-2010 Zerbi, Alessandro; Falconi, Massimo; Rindi, Guido; Fave, Gianfranco Delle; Tomassetti, Paola; Pasquali, Claudio; Capitanio, Vanessa; Boninsegna, Letizia; Di Carlo, Valerio; Gebbia, Vittorio
First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale 1-gen-2010 Gebbia, V; Lorusso, V; Galetta, D; Caruso, M M; Palomba, G; Riccardi, F; Borsellino, N; Carrozza, F; Leo, S; Ferraù, F; Cinieri, S; Mancuso, G; Mancarella, S; Colucci, G.
Breakthrough pain in oncology: a longitudinal study 1-gen-2010 Mercadante, S; Zagonel, V; Breda, E; Arcara, C; Gebbia, V; Porzio, G; Aielli, F; David, F; Gammucci, T; Narducci, F; Lanzetta, G; Restuccia, R; Lembo, A; Passeri, V; Virzì, V; Casuccio, Alessandra
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 6.901 a 6.920 di 15.818
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista15814
  • 4 Contributo in Atti di Convegno ...2
  • 2 Contributo in Volume1
Autore
  • BARBANTI, MARCO461
  • PAPPALARDO, FEDERICO345
  • GEBBIA, VITTORIO333
  • DOMINGUEZ RODRIGUEZ, LIGIA JULIANA332
  • TUMINO, AURORA313
  • MANIACI, ANTONINO309
  • GULINO, MARISA283
  • ELIA, MAURIZIO281
  • UMANA, GIUSEPPE EMMANUELE277
  • MAGGI, PAOLO260
Data di pubblicazione
  • In corso di stampa18
  • 2020 - 20267356
  • 2010 - 20195871
  • 2000 - 20091990
  • 1990 - 1999520
  • 1980 - 198961
  • 1979 - 19791
Editore
  • Trans Tech Publications1
Rivista
  • INTERNATIONAL JOURNAL OF MOLECULA...230
  • JOURNAL OF CLINICAL MEDICINE162
  • CANCERS127
  • INTERNATIONAL JOURNAL OF ENVIRONM...118
  • LNS. ACTIVITY REPORT85
  • DIAGNOSTICS82
  • PHD KORE REVIEW78
  • RIVISTA DELLA COOPERAZIONE GIURID...76
  • SCIENTIFIC REPORTS75
  • SUSTAINABILITY73
Serie
  • ADVANCED MATERIALS RESEARCH1
  • WORKING PAPERS RES1
Keyword
  • Humans266
  • COVID-19261
  • Female141
  • Male131
  • SARS-CoV-2109
  • inflammation106
  • oxidative stress85
  • Italy80
  • Adult72
  • Middle Aged72
Lingua
  • eng11136
  • ita2599
  • fre66
  • spa65
  • lat12
  • ger11
  • por6
  • ara3
  • cat3
  • enm2
Accesso al fulltext
  • no fulltext15817